Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106977572A reveals a novel two-step synthesis route for lithocholic acid offering high purity and significant supply chain cost reduction advantages.
Patent CN108503586A reveals advanced purification for tolvaptan intermediates. Achieve >99% purity and reduced impurity M for reliable pharmaceutical intermediates supply chains.
Patent CN113429407B details a metal-free acid-catalyzed route to 1-alkyl-3-aryl indolizines, offering significant cost reduction and scalability for API manufacturing.
Patent CN113429407B details acid-catalyzed cyclization for indolizines, offering scalable routes for pharmaceutical intermediates with reduced metal contamination.
Patent CN101016293A details a catalyst-free route for imatinib intermediates, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN105315167A reveals a one-step chiral synthesis. This method offers high selectivity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN1152033C details efficient synthesis of pyrazolopyrimidines for insomnia treatment, offering streamlined routes and cost reduction in API manufacturing.
Patent CN100345819C reveals a cleaner route for substituted amantadine compounds, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN116217646B reveals a high-yield route for 16α-hydroxyprednisone intermediates. Discover cost-effective manufacturing and supply chain advantages for asthma medications.
Patent CN1203059C reveals a novel high-yield route for torasemide intermediates. Discover how this advanced chemistry drives cost reduction in diuretic manufacturing and ensures supply chain stability.
Advanced catalytic method for paroxetine intermediate synthesis. Enhances optical purity and supply chain reliability for global pharmaceutical manufacturing partners.
Novel bromohydroxylation method improves purity and yield for steroid intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel halohydrin route for Entecavir intermediate N4 avoids hazardous epoxidation, offering safer scale-up and cost efficiency for antiviral manufacturing.
Patent CN103242272A reveals a safer route avoiding phosgene and late-stage bromination, ensuring high purity and supply chain stability for gout medication manufacturers.
Novel copper-catalyzed synthesis of quinoline fused rings. Cost-effective, scalable process for pharma intermediates. Reliable supply chain partner.
Novel antimicrobial intermediates with broad-spectrum activity against MRSA and fungi. Efficient three-step synthesis route offers significant cost advantages for API manufacturing.
Patent CN102603691B reveals high-yield synthesis for influenza intermediates. Reduces hazardous steps and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN119095829A reveals safer chlorination route. Reduces impurities and enhances supply chain stability for pharmaceutical intermediates manufacturing.
Advanced process for phosphine oxide vitamin D precursors using triphosgene chlorination. Reliable supplier offering cost reduction in pharmaceutical intermediate manufacturing.
Novel preparation method for AHU-377 intermediates ensures high chiral purity and yield. Optimized supply chain for pharmaceutical manufacturing partners seeking reliable production.